{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:58:58Z","timestamp":1792180738570,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clnesp.2025.06.014","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:38:45Z","timestamp":1749757125000},"page":"737-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Loss of skeletal muscle mass during treatment is associated with reduced overall survival in gastric cancer patients undergoing conversion surgery"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-5218","authenticated-orcid":false,"given":"Marta","family":"Sandini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Bagnacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ricchiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gambassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Capitoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Mazzei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Marrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10294","key":"10.1016\/j.clnesp.2025.06.014_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.clnesp.2025.06.014_bib2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1080\/14796694.2024.2342107","article-title":"Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary","volume":"20","author":"Shitara","year":"2024","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.06.014_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10147-020-01820-9","article-title":"Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan","volume":"26","author":"Nakao","year":"2021","journal-title":"Int J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clnesp.2025.06.014_bib4","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1245\/s10434-020-08559-7","article-title":"Surgical outcome and long-term survival of conversion surgery for advanced gastric cancer","volume":"27","author":"Chen","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.06.014_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.109485","article-title":"Effectiveness of conversion surgery in stage IV gastric cancer","volume":"51","author":"Dat","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.06.014_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","article-title":"Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification","volume":"19","author":"Yoshida","year":"2016","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.clnesp.2025.06.014_bib7","volume":"11","author":"Ding","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.clnesp.2025.06.014_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11113097","article-title":"The clinical implication of conversion surgery in patients with stage IV gastric cancer who received systemic chemotherapy","volume":"11","author":"Shin","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2025.06.014_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10120-017-0722-9","article-title":"Sarcopenia in gastric cancer: when the loss costs too much","volume":"20","author":"Ongaro","year":"2017","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.clnesp.2025.06.014_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SPC.0000000000000011","article-title":"Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer","volume":"7","author":"Antoun","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"issue":"7","key":"10.1016\/j.clnesp.2025.06.014_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnesp.2025.06.014_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2021.104534","article-title":"Impact of preoperative sarcopenia on postoperative complications and prognosis of gastric cancer resection: a meta-analysis of cohort studies","volume":"98","author":"Chen","year":"2022","journal-title":"Arch Gerontol Geriatr"},{"issue":"7","key":"10.1016\/j.clnesp.2025.06.014_bib14","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.clnu.2019.10.021","article-title":"Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis","volume":"39","author":"Rinninella","year":"2020","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00423-024-03574-8","article-title":"Prognostic significance of osteosarcopenia in patients with stage IV gastric cancer undergoing conversion surgery","volume":"410","author":"Hirase","year":"2024","journal-title":"Langenbecks Arch Surg"},{"issue":"9","key":"10.1016\/j.clnesp.2025.06.014_bib16","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.21873\/anticanres.17232","article-title":"Clinical significance of body weight loss during chemotherapy for advanced gastric cancer undergoing conversion surgery","volume":"44","author":"Arigami","year":"2024","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.clnesp.2025.06.014_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamasurg.2018.0979","article-title":"Association between changes in body composition and neoadjuvant treatment for pancreatic cancer","volume":"153","author":"Sandini","year":"2018","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.clnesp.2025.06.014_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10120-016-0615-3","article-title":"The Italian research group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015","volume":"20","author":"De Manzoni","year":"2017","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.clnesp.2025.06.014_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for research and treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.clnesp.2025.06.014_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ajcn\/80.2.271","article-title":"Visceral adipose tissue: relations between single-slice areas and total volume","volume":"80","author":"Shen","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.06.014_bib22","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"1985","journal-title":"J Appl Physiol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.06.014_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu12030755","article-title":"Reference values for skeletal muscle mass - current concepts and methodological considerations","volume":"12","author":"Walowski","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcsm.12484","article-title":"Prognostic role of body composition parameters in gastric\/gastroesophageal junction cancer patients from the EXPAND trial","volume":"11","author":"Hacker","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000502613","article-title":"Correlation between skeletal muscle mass and adverse events of neoadjuvant chemotherapy in patients with gastric cancer","volume":"98","author":"Matsuura","year":"2020","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.clnesp.2025.06.014_bib26","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1245\/s10434-018-6624-1","article-title":"Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC trial","volume":"25","author":"Park","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clnesp.2025.06.014_bib27","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1007\/s00268-023-07200-4","article-title":"Impact of frailty and sarcopenia on Short- and long-term outcomes in elderly patients undergoing radical gastrectomy for gastric cancer","volume":"47","author":"Osaki","year":"2023","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.clnesp.2025.06.014_bib28","doi-asserted-by":"crossref","DOI":"10.1590\/1806-9282.20230568","article-title":"Clinical significance of sarcopenia in patients undergoing treatment for gastric cancer","volume":"69","author":"Ozcan","year":"1992","journal-title":"Rev Assoc Med Bras"},{"issue":"2","key":"10.1016\/j.clnesp.2025.06.014_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00595-024-02902-1","article-title":"The impact of preoperative skeletal muscle loss on the completion of S-1 adjuvant chemotherapy for gastric cancer","volume":"55","author":"Nakabayashi","year":"2025","journal-title":"Surg Today"},{"issue":"3","key":"10.1016\/j.clnesp.2025.06.014_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030960","article-title":"Body composition changes in gastric cancer patients during preoperative FLOT therapy: preliminary results of an Italian cohort study","volume":"13","author":"Rinninella","year":"2021","journal-title":"Nutrients"},{"issue":"13","key":"10.1016\/j.clnesp.2025.06.014_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16132408","article-title":"Impact of neoadjuvant treatment on body composition in patients with locally advanced gastric cancer","volume":"16","author":"Juez","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clnesp.2025.06.014_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-319-70178-3_2","article-title":"Sex differences in body composition","volume":"1043","author":"Bredella","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ajco.13514","article-title":"Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long-term outcomes after gastrectomy","volume":"18","author":"Horii","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5230\/jgc.2017.17.e8","article-title":"Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer","volume":"17","author":"Palmela","year":"2017","journal-title":"J Gastric Cancer"},{"key":"10.1016\/j.clnesp.2025.06.014_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.111135","article-title":"Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment","volume":"85","author":"Zhang","year":"2021","journal-title":"Nutrition"},{"issue":"10","key":"10.1016\/j.clnesp.2025.06.014_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103349","article-title":"Assessment of nutritional status and nutrition impact symptoms in patients undergoing resection for upper gastrointestinal cancer: results from the multi-centre NOURISH point prevalence study","volume":"13","author":"Deftereos","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2025.06.014_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2025.06.014_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-277X.2003.00459.x","article-title":"Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy","volume":"16","author":"Harvie","year":"2003","journal-title":"J Hum Nutr Diet"},{"issue":"3","key":"10.1016\/j.clnesp.2025.06.014_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jhn.12861","article-title":"Marked loss of adipose tissue during neoadjuvant therapy as a predictor for poor prognosis in patients with gastric cancer: a retrospective cohort study","volume":"34","author":"Zhang","year":"2021","journal-title":"J Hum Nutr Diet"},{"issue":"10","key":"10.1016\/j.clnesp.2025.06.014_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/nu15102241","article-title":"Neoadjuvant gastric cancer treatment and associated nutritional critical domains for the optimization of care pathways: a systematic review","volume":"15","author":"Correia","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2025.06.014_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ags3.12515","article-title":"International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1)","volume":"6","author":"Yoshida","year":"2022","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.clnesp.2025.06.014_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.852559","article-title":"Conversion surgery in gastric cancer carcinomatosis","volume":"12","author":"Morgagni","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.clnesp.2025.06.014_bib43","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer","volume":"45","author":"Johns","year":"2013","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725003602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725003602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:32:12Z","timestamp":1752766332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725003602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":43,"alternative-id":["S2405457725003602"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.06.014","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of skeletal muscle mass during treatment is associated with reduced overall survival in gastric cancer patients undergoing conversion surgery","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}